Actemra 160mg, a treatment known scientifically as tocilizumab, is a a potent pharmaceutical agent primarily employed for the management of rheumatoid arthritis. This remarkable agent operates by blocking the activity of interleukin-6 (IL-6), a signaling protein vital in the inflammatory process. Furthermore, Actemra exhibits promise in the manage